Latest Updates - Page 465 of 1526 - Express Pharma

Alembic Pharma receives US FDA final approval for Lacosamide tablets

AstraZeneca COVID drug neutralises Omicron sub-variants in lab study

Hetero receives CDSCO approval to manufacture Sputnik Light vaccine for sale in India

Glenmark Pharma receives ANDA approval for Lacosamide tablets

Second Covishield dose can be given between eight to16 weeks after first dose: NTAGI

US FDA approves new Bristol Myers cancer immunotherapy

US FDA approves Marinus Pharma’s lead drug to treat genetic disorder

Biolexis to collaborate with Akston Biosciences for COVID-19 vaccine

Zydus receives PAS approval from US FDA for Mycophenolate Mofetil for injection

MSF responds to potential compromise to ‘TRIPS Waiver’